Kestra Medical Technologies, Lt (KMTS) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Adjusted EPS
- -$0.46
- Estimate
- -$0.62
- Surprise
- +26.7%
- Revenue (period 2026-07-31)
- $31.0M
- Score at report (before → after)
- 5.6 → 5.5/10
Revenue source: xbrl.
How the report landed
Kestra Medical Technologies, Lt (KMTS) reported a narrower loss than forecast — adjusted EPS of -$0.46 against the -$0.62 estimate (a 26.7% beat on a still-unprofitable quarter). TrendMatrix's engine moved from Hold (5.6/10) to Sell at 5.5/10 after the report — the engine's score fell despite the beat.
Coverage in the report window
- Kestra Medical Technologies Posts Mixed Q1 Results, Joins Enova International, Dave and Buster's And Other Big Stocks Mo — benzinga, 2026-09-15
- Why Veea Shares Are Trading Higher By 58%; Here Are 20 Stocks Moving Premarket — benzinga, 2026-09-15
- Transcript: Kestra Medical Techs Q1 2027 Earnings Conference Call — benzinga, 2026-09-14
Where TrendMatrix's rating stands now
TrendMatrix currently rates KMTS Sell at 5.1/10.
4 of the last 4 quarters beat the estimate; this quarter's +26.7% surprise compares with a +23.7% four-quarter average. Next scheduled report: 2026-12-14.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (4/4)
What argues against it
- Concentration risk — Product: ASSURE WCD
- Concentration risk — Counterparty: third-party payors including Medicare and Medicaid
- Analyst target reached - limited upside remaining
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $27.10
- Price target
- $29.07
- Stop
- $25.20
- Upside to target
- +7.3%
Model outputs from TrendMatrix’s engine as of 2026-10-07 — shown for context, not personalized investment advice.
KMTS at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Instruments & Supplies
- Market cap
- $1.69B
- P/E (fwd)
- -13.8
- 52-week range
- $17.34–$30.00
- Off 52-week high
- 9.7%
- RSI (14)
- 66
- Volume vs avg
- 0.60×
- Score today
- 5.1/10